US20140275613A1 - Conversion of free fatty acids to ethyl esters - Google Patents
Conversion of free fatty acids to ethyl esters Download PDFInfo
- Publication number
- US20140275613A1 US20140275613A1 US14/025,740 US201314025740A US2014275613A1 US 20140275613 A1 US20140275613 A1 US 20140275613A1 US 201314025740 A US201314025740 A US 201314025740A US 2014275613 A1 US2014275613 A1 US 2014275613A1
- Authority
- US
- United States
- Prior art keywords
- mixture
- approximately
- acid
- free fatty
- aqueous phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000021588 free fatty acids Nutrition 0.000 title claims abstract description 44
- 125000004494 ethyl ester group Chemical group 0.000 title claims abstract description 22
- 238000006243 chemical reaction Methods 0.000 title description 18
- 239000000203 mixture Substances 0.000 claims abstract description 75
- 238000000034 method Methods 0.000 claims abstract description 56
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000008346 aqueous phase Substances 0.000 claims abstract description 20
- 239000012071 phase Substances 0.000 claims abstract description 19
- 239000002253 acid Substances 0.000 claims abstract description 18
- 239000012454 non-polar solvent Substances 0.000 claims abstract description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 9
- 239000011707 mineral Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- -1 naphtha Chemical compound 0.000 claims description 15
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 12
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims description 11
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 10
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 10
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 9
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 9
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 9
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 claims description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 8
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 8
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims description 7
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 7
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 235000021319 Palmitoleic acid Nutrition 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 4
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 4
- 239000008096 xylene Substances 0.000 claims description 4
- 241000611184 Amphora Species 0.000 claims description 3
- 241000192542 Anabaena Species 0.000 claims description 3
- 241001536324 Botryococcus Species 0.000 claims description 3
- 241000227752 Chaetoceros Species 0.000 claims description 3
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 3
- 241000180279 Chlorococcum Species 0.000 claims description 3
- 241001147476 Cyclotella Species 0.000 claims description 3
- 241000206743 Cylindrotheca Species 0.000 claims description 3
- 241000195634 Dunaliella Species 0.000 claims description 3
- 241000200106 Emiliania Species 0.000 claims description 3
- 241000195620 Euglena Species 0.000 claims description 3
- 241000705948 Glossomastix Species 0.000 claims description 3
- 241000168525 Haematococcus Species 0.000 claims description 3
- 241001501885 Isochrysis Species 0.000 claims description 3
- 241000013738 Monochrysis Species 0.000 claims description 3
- 241001478792 Monoraphidium Species 0.000 claims description 3
- 241000196305 Nannochloris Species 0.000 claims description 3
- 241000224474 Nannochloropsis Species 0.000 claims description 3
- 241000502321 Navicula Species 0.000 claims description 3
- 241001442227 Nephroselmis Species 0.000 claims description 3
- 241000180701 Nitzschia <flatworm> Species 0.000 claims description 3
- 241000059630 Nodularia <Cyanobacteria> Species 0.000 claims description 3
- 241000192656 Nostoc Species 0.000 claims description 3
- 241000514008 Oocystis Species 0.000 claims description 3
- 241000192497 Oscillatoria Species 0.000 claims description 3
- 241000206766 Pavlova Species 0.000 claims description 3
- 241000206731 Phaeodactylum Species 0.000 claims description 3
- 241000196317 Platymonas Species 0.000 claims description 3
- 241000722208 Pleurochrysis Species 0.000 claims description 3
- 241000206609 Porphyra Species 0.000 claims description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 3
- 241000192511 Pseudanabaena Species 0.000 claims description 3
- 241001509341 Pyramimonas Species 0.000 claims description 3
- 241000195663 Scenedesmus Species 0.000 claims description 3
- 241001148696 Stichococcus Species 0.000 claims description 3
- 241000192707 Synechococcus Species 0.000 claims description 3
- 241000192584 Synechocystis Species 0.000 claims description 3
- 241000196321 Tetraselmis Species 0.000 claims description 3
- 241001491691 Thalassiosira Species 0.000 claims description 3
- 241000192118 Trichodesmium Species 0.000 claims description 3
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 3
- 235000012162 pavlova Nutrition 0.000 claims description 3
- 229910015900 BF3 Inorganic materials 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims 5
- 230000008569 process Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 239000000047 product Substances 0.000 abstract description 3
- 230000003796 beauty Effects 0.000 abstract description 2
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 20
- 229930195729 fatty acid Natural products 0.000 description 20
- 239000000194 fatty acid Substances 0.000 description 20
- 150000004665 fatty acids Chemical class 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 150000002632 lipids Chemical class 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- 238000003860 storage Methods 0.000 description 11
- 241000195493 Cryptophyta Species 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 9
- 150000002190 fatty acyls Chemical class 0.000 description 8
- 230000015654 memory Effects 0.000 description 8
- 150000004712 monophosphates Chemical class 0.000 description 7
- 235000021354 omega 7 monounsaturated fatty acids Nutrition 0.000 description 7
- 125000005340 bisphosphate group Chemical group 0.000 description 6
- 229940106189 ceramide Drugs 0.000 description 6
- 150000002313 glycerolipids Chemical class 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 150000002327 glycerophospholipids Chemical class 0.000 description 5
- 150000003410 sphingosines Chemical class 0.000 description 5
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 4
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 150000003313 saccharo lipids Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 150000002339 glycosphingolipids Chemical class 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 150000003408 sphingolipids Chemical class 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000195628 Chlorophyta Species 0.000 description 2
- 241000206751 Chrysophyceae Species 0.000 description 2
- 241000199914 Dinophyceae Species 0.000 description 2
- 241000195623 Euglenida Species 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 241000206572 Rhodophyta Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000206764 Xanthophyceae Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 150000001977 di-glycerol tetraether phospholipids Chemical class 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 150000002316 glycerophosphocholines Chemical class 0.000 description 2
- 150000002317 glycerophosphoethanolamines Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 239000010773 plant oil Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- SBHCLVQMTBWHCD-METXMMQOSA-N (2e,4e,6e,8e,10e)-icosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C(O)=O SBHCLVQMTBWHCD-METXMMQOSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- MEAZTWJVOWHKJM-CIAPRIGGSA-N 1-(3-O-sulfo-beta-D-galactosyl)-N-tetracosanoylsphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(O)(=O)=O)[C@H]1O MEAZTWJVOWHKJM-CIAPRIGGSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 150000000320 1Z-alkenylacylglycerols Chemical class 0.000 description 1
- 150000000321 1Z-alkenyldiacylglycerols Chemical class 0.000 description 1
- LRYZPFWEZHSTHD-HEFFAWAOSA-O 2-[[(e,2s,3r)-2-formamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium Chemical class CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](NC=O)COP(O)(=O)OCC[N+](C)(C)C LRYZPFWEZHSTHD-HEFFAWAOSA-O 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- AERBNCYCJBRYDG-RGBJRUIASA-N 4-hydroxysphinganine Chemical class CCCCCCCCCCCCCCC(O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-RGBJRUIASA-N 0.000 description 1
- OYHQOLUKZRVURQ-UHFFFAOYSA-N 9,12-Octadecadienoic Acid Chemical compound CCCCCC=CCC=CCCCCCCCC(O)=O OYHQOLUKZRVURQ-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 102000015303 Fatty Acid Synthases Human genes 0.000 description 1
- 108010039731 Fatty Acid Synthases Proteins 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- 241001491705 Macrocystis pyrifera Species 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 150000001201 N-acylsphingosines Chemical class 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- CNVZJPUDSLNTQU-UHFFFAOYSA-N Petroselaidic acid Natural products CCCCCCCCCCCC=CCCCCC(O)=O CNVZJPUDSLNTQU-UHFFFAOYSA-N 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001270 acylaminosugar glycans Chemical class 0.000 description 1
- 150000001271 acylaminosugars Chemical class 0.000 description 1
- 150000001274 acyltrehalose glycans Chemical class 0.000 description 1
- 150000001275 acyltrehaloses Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001355 alkyl diacyl glycerols Chemical class 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 150000001496 arsenosphingolipids Chemical class 0.000 description 1
- MCWVPSBQQXUCTB-OQTIOYDCSA-N avenasterol Chemical class C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CC/C(=C/C)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 MCWVPSBQQXUCTB-OQTIOYDCSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical class C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001769 cdp-glycerols Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-N cis-vaccenic acid Chemical compound CCCCCC\C=C/CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-FPLPWBNLSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 150000001976 di-glycerol tetraether glycans Chemical class 0.000 description 1
- 150000001978 di-glycerol tetraethers Chemical class 0.000 description 1
- 150000001980 diacylaminosugars Chemical class 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- 150000001985 dialkylglycerols Chemical class 0.000 description 1
- 150000001986 dialkylmonoacylglycerols Chemical class 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 150000002001 dihydroceramides Chemical class 0.000 description 1
- 150000002015 diradylglycerols Chemical class 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- KFEVDPWXEVUUMW-UHFFFAOYSA-N docosanoic acid Natural products CCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 KFEVDPWXEVUUMW-UHFFFAOYSA-N 0.000 description 1
- 150000002066 eicosanoids Chemical class 0.000 description 1
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 150000002149 estolides Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 150000002233 fucosterols Chemical class 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 150000002312 glycerol-nonitol tetraether phospholipids Chemical class 0.000 description 1
- 150000002315 glycerophosphates Chemical class 0.000 description 1
- 150000002319 glycerophosphoglycerols Chemical class 0.000 description 1
- 150000002320 glycerophosphoglycerophosphates Chemical class 0.000 description 1
- 150000002321 glycerophosphoglycerophosphoglycerols Chemical class 0.000 description 1
- 150000002322 glycerophosphoinositol bisphosphates Chemical class 0.000 description 1
- 150000002323 glycerophosphoinositol monophosphates Chemical class 0.000 description 1
- 150000002324 glycerophosphoinositol trisphosphates Chemical class 0.000 description 1
- 150000002325 glycerophosphoinositolglycans Chemical class 0.000 description 1
- 150000002326 glycerophosphoinositols Chemical class 0.000 description 1
- 150000002328 glycerophosphonocholines Chemical class 0.000 description 1
- 150000002329 glycerophosphonoethanolamines Chemical class 0.000 description 1
- 150000002330 glycerophosphoserines Chemical class 0.000 description 1
- 150000002331 glyceropyrophosphates Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002393 hexaacylaminosugars Chemical class 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical group [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002517 isofucosterols Chemical class 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- LTYOQGRJFJAKNA-IJCONWDESA-N malonyl-coenzyme a Chemical group O[C@@H]1[C@@H](OP(O)(O)=O)[C@H](CO[P@](O)(=O)O[P@@](O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-IJCONWDESA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002753 mono-(1Z-alkenyl)-glycerols Chemical class 0.000 description 1
- 150000002759 monoacylglycerols Chemical class 0.000 description 1
- 150000002761 monoalkylglycerols Chemical class 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002770 monoradylglycerols Chemical class 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 150000002812 neutral glycosphingolipids Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000005830 nonesterified fatty acids Chemical class 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000021032 oily fish Nutrition 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 150000002922 oxidized glycerophospholipids Chemical class 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 150000002963 pentaacylaminosugars Chemical class 0.000 description 1
- 239000013520 petroleum-based product Substances 0.000 description 1
- CNVZJPUDSLNTQU-SEYXRHQNSA-N petroselinic acid Chemical compound CCCCCCCCCCC\C=C/CCCCC(O)=O CNVZJPUDSLNTQU-SEYXRHQNSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003010 phosphonosphingolipids Chemical class 0.000 description 1
- 150000003019 phosphosphingolipids Chemical class 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 229930000756 phytoceramide Natural products 0.000 description 1
- 150000003038 phytosphingosines Chemical class 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 239000010801 sewage sludge Substances 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical class C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical class C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 150000003517 tetraacylaminosugars Chemical class 0.000 description 1
- QZZGJDVWLFXDLK-UHFFFAOYSA-N tetracosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003647 triradylglycerols Chemical class 0.000 description 1
- 239000002383 tung oil Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/16—Fatty acid esters
- A21D2/165—Triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/001—Refining fats or fatty oils by a combination of two or more of the means hereafter
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/02—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/08—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with fatty acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/187—Eicosapentaenoic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1876—Long-chain fatty acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/202—Algae extracts
Definitions
- the present invention is directed to systems and methods for producing ethyl esters from free fatty acids.
- Various embodiments of the present invention include systems and methods for converting free fatty acids into ethyl esters.
- An exemplary method may comprise contacting the free fatty acid with a non-polar solvent.
- a mineral acid and an alcohol may then be added to form a two-phase mixture.
- An aqueous phase may subsequently be removed from the mixture.
- FIG. 1 is general flow chart of an exemplary method for producing ethyl esters.
- FIG. 2 is a flow chart of an exemplary method for converting free fatty acids to ethyl esters.
- An exemplary method may comprise contacting the free fatty acid with a non-polar solvent to form a first mixture.
- An acid and an alcohol may then be added to form a second mixture.
- the second mixture may be heated and agitated to form a two-phase mixture, and an aqueous phase may be removed from the two-phase mixture.
- the processes and methods may be used in the manufacture of supplements, pharmaceuticals, cosmetic and beauty products, feedstocks, and the like.
- Lipids are a broad class of chemical compounds that may be defined as “fatty acids and their derivatives, and the substances related biosynthetically or functionally to these compounds” [W. W. Christie, Gas Chromatography and Lipids: A Practical Guide (1989), p. 5]. Most lipids are soluble in organic solvents, but many are insoluble in water; however, given the diverse nature of lipids, some compounds regarded as lipids may also be soluble in water.
- Organic solvents in which lipids are soluble are generally non-polar solvents and may include pentane, cyclopentane, hexane, cyclohexane, benzene, toluene, 1,4-dioxane, chloroform, diethyl ether, methylene chloride, ethyl acetate, d-limonene, heptane, naphtha, and xylene, among others.
- Higher melting point lipids are typically solids at room temperature and are broadly classified as fats or waxes. Lipids with lower melting points are typical liquids at room temperature and are broadly classified as oils. Free fatty acids may be defined as non-esterified fatty acids.
- lipids are based on the biochemical subunits from which the lipids originate. This system provides for various general categories of biological lipids, including fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, saccharolipids, sterol lipids, and glycolipids.
- Fatty acyls are straight-chain carbon compounds that may be naturally synthesized via condensation of malonyl coenzyme A units by a fatty acid synthase complex.
- Fatty acyls typically have a carbon chain comprised of 4 to 24 carbon atoms, and often terminate with a carboxyl group (—COOH).
- Lipids containing fatty acyls can be hydrolyzed into alkali fatty acid salts using basic hydrolysis, a process known as saponification.
- Fatty acyls may be saturated or unsaturated, and may also include functional groups containing oxygen, nitrogen, sulfur, and halogens.
- Fatty acyls found in plant tissues commonly have a carbon chain comprised of 14, 16, 18, 20, or 24 carbon atoms.
- Common fatty acyls of plant and animal origin can be divided into three broad categories of saturated fatty acids, monoenoic fatty acids, and polyunsaturated fatty acids.
- Saturated fatty acids are characterized as having 2 or more carbon atoms in the carbon chain with no double bonds between any of the carbon atoms.
- Example saturated fatty acids include ethanoic acid, butanoic acid, hexanoic acid, octanoic acid, decanoic acid, dodecanoic acid, tetradecanoic acid, hexadecanoic acid, octadecanoic acid, eicosanoic acid, docosanoic acid, and tetracosanoic acid.
- Monoenoic fatty acids are characterized as having a single carbon-carbon double bond in the carbon chain.
- the double bond is typically a cis-configuration, although some trans-configuration compounds are known.
- Example monoenoic fatty acids include cis-9-hexadecenoic acid, cis-6-octadecenoic acid, cis-9-octadecenoic acid, cis-11-octadecenoic acid, cis-13-docosenoic acid, and cis-15-tetracosenoic acid.
- Polyunsaturated fatty acids are characterized as having two or more carbon-carbon double bonds in the carbon chain.
- Example polyunsaturated fatty acids include 9,12-octadecadienoic acid, 6,9,12-octadecatrienoic acid, 9,12,15-octadecatrienoic acid, 5,8,11,14-eicosatetraenoic acid, 5,8,11,14,17-eicosapentaenoic acid, and 4,7,10,13,16,19-docosahexanoic acid.
- Glycerolipids may be formed by joining fatty acids to glycerol by ester bonds. The majority of glycerolipids are formed by mono-, di-, or tri-substitution of fatty acids on the glycerol molecule. The most common naturally occurring glycerolipids are of the tri-substituted variety, known as triacylglycerols or triglycerides.
- Example glycerolipids include monoradylglycerols, monoacylglycerols, monoalkylglycerols, mono-(1Z-alkenyl)-glycerols, diradylglycerols, diacylglycerols, 1-alkyl,2-acylglycerols, 1-acyl,2-alkylglycerols, dialkylglycerols, 1Z-alkenylacylglycerols, di-glycerol tetraethers, di-glycerol tetraether glycans, triradylglycerols, triacylglycerols, alkyldiacylglycerols, dialkylmonoacylglycerols, 1Z-alkenyldiacylglycerols, estolides, glycosylmonoradylglycerols, glycosylmonoacylglycerols, glyco
- Glycerophospholipids may be characterized by fatty acids linked through an ester oxygen to the first and second carbon atoms of the glycerol molecule, with a phosphate functional group ester-linked to the third carbon atom to the glycerol molecule. Other functional groups may also be linked to the phosphate functional group.
- glycerophospholipids may serve as structural components of the cell membrane.
- Example glycerophospholipids include phosphatidyl choline (lecithin), phosphatidyl ethanolamine (cephalin), phosphatidyl inositol, phosphatidylserine, bisphosphatidylglycerol (cardiolipin), glycerophosphocholines, diacylglycerophosphocholines, 1-alkyl,2-acylglycerophosphocholines, 1-acyl,2-alkylglycerophosphocholines, 1Z-alkenyl,2-acylglycerophosphocholines, dialkylglycerophosphocholines, monoacylglycerophosphocholines, monoalkylglycerophosphocholines, 1Z-alkenylglycerophosphocholines, glycerophosphoethanolamines, diacylglycerophosphoethanolamines, 1-alkyl,2-acylglycerophosphoethanolamines, 1-acyl,2-alkylglycerophosphoethanolamines, 1
- Sphingolipids may be characterized by a long-chain base (typically 12 to 26 carbon atoms) linked by an amide bond to a fatty acid and via a terminal hydroxyl group to complex carbohydrates or phosphorous functional groups. These lipids play important roles in signal transmission between cells and cell recognition.
- Example sphingolipids include sphing-4-enines (sphingosines), sphinganines, 4-hydroxysphinganines (phytosphingosines), sphingoid base homologs and variants, sphingoid base 1-phosphates, lysosphingomyelins and lysoglycosphingolipids, N-methylated sphingoid bases, sphingoid base analogs, ceramides, N-acylsphingosines (ceramides), N-acylsphinganines (dihydroceramides), N-acyl-4-hydroxysphinganines (phytoceramides), acylceramides, ceramide 1-phosphates, phosphosphingolipids, ceramide phosphocholines (sphingomyelins), ceramide phosphoethanolamines, ceramide phosphoinositols, phosphonosphingolipids, neutral glycosphingolipids, simple Glc series
- Saccharolipids may be comprised of fatty acids linked directly to a sugar backbone. Typically, a monosaccharide takes the place of the glycerol molecule that forms the backbone of other lipids such as glycerolipids and glycerophospholipids. Saccharolipids play a role in the bilayer structure of cell membranes.
- Example saccharolipids include acylaminosugars, monoacylaminosugars, diacylaminosugars, triacylaminosugars, tetraacylaminosugars, pentaacylaminosugars, hexaacylaminosugars, heptaacylaminosugars, acylaminosugar glycans, acyltrehaloses, and acyltrehalose glycans.
- Glycoglycerolipids may be comprised of fatty acids linked through an ester oxygen to the first and second carbons of a glycerol molecule, with a carbohydrate functional group ester-linked to the third carbon atom.
- the carbohydrate functional group may include one or more sugar monomers.
- Other functional groups may also be linked to the carbohydrate functional group.
- Example glycoglycerolipids include monogalactosyldiacylglycerols, digalactosyldiacylglycerols, trigalactosyldiacylglycerols, tetragalactosyldiacylglycerols, polygalactosyldiacylglycerols, monoglucosyldiacylglycerols, diglucosyldiacylglycerols, monogalactosylmonoacylglycerols, digalactosylmonoacylglycerols, sulfoquinovosyldiacylglycerols, acylsulfoquinovosyldiacylglycerols, acylgalactosylglucossyldiacylglycerols, kojibiosyldiaacylglycerols, galactofuranosyldiacy
- Sterol esters may be characterized as comprising alcohols sharing a fused four-ring steroid structure ester-linked to one or more fatty acyls.
- Examples include cholesteryl esters, campesterol esters, stigmasterol esters, sitosterol esters, avenasterol esters, fucosterol esters, isofucosterol esters, and ethylcholesteryl esters.
- FIG. 1 illustrates a general process for converting free fatty acids into ethyl esters.
- Free fatty acids may be obtained from a variety of sources. For example, crude algal oil obtained from various algae species may be converted to free fatty acids in an aqueous system (step 105 ). The crude algal oil is typically a mixture of oils, waxes, chlorophyll, and other species that originally supported the functioning of the algae plant. The free fatty acids may be extracted from other algal impurities.
- the free fatty acids may be mixed with a mineral acid and an alcohol to impart a phase separation of the mixture.
- An esterification reaction may occur (step 115 ) to convert the free fatty acids to the ethyl ester form.
- the ethyl esters may then be isolated from the mixture (step 120 ).
- Esterification is the chemical process of producing esters.
- esters are formed from a fatty acid and an alcohol.
- carboxylic acid a fatty acid
- carboxylic acid may react with ethanol in the presence of an acid catalyst to produce ethyl esters and water according to Equation 1.
- Equation 1 The reaction of Equation 1 is also reversible in that the water formed will react with the ethyl ester in the presence of an acid to produce free fatty acids. This reverse reaction has a higher propensity to occur than the esterification reaction, meaning that the produced water should be removed from the reaction mixture to achieve higher conversion of the free fatty acid. Without removal of the water, a reaction mixture of 10 percent water and 90 percent ethanol on a molar basis may produce a mixture that is approximately 30 percent free fatty acid and 70 percent ethyl ester on a molar basis (that is, about a 70 percent conversion).
- various algae species may be the source of the crude algal oil from which the free fatty acids may be obtained.
- Algae are mostly aquatic photosynthetic organisms that range from microscopic flagellate to giant kelp. Algae may be loosely grouped into seven categories: Euglenophyta (euglenoids), Chrysophyta (golden-brown algae), Pyrrophyta (fire algae), Dinoflagellata, Chlorophyta (green algae), Rhodophyta (red algae), Paeophyta (brown algae), and Xanthophyta (yellow-green algae).
- Lipid extracted from any algae genus may be used in the various embodiments of the present invention, including Amphora, Anabaena, Anikstrodesmis, Botryococcus, Chaetoceros, Chlorella, Chlorococcum, Cyclotella, Cylindrotheca, Dunaliella, Emiliania, Euglena, Glossomastix, Haematococcus, Isochrysis, Monochrysis, Monoraphidium, Nannochloris, Nannochloropsis, Navicula, Nephrochloris, Nephroselmis, Nitzschia, Nodularia, Nostoc, Oochromonas, Oocystis, Oscillatoria, Pavlova, Phaeodactylum, Picochloris, Platymonas, Pleurochrysis, Porphyra, Pseudoanabaena, Pyramimonas, Scenedesmus, Stichococcus, Synecho
- non-algae sources such as plant oils and animal oils may also be used in various embodiments, as may various petroleum-based products and synthetic oils.
- sources of non-algae free fatty acids include fish oil, tung oil, colza oil, soy bean oil, corn oil, peanut oil, palm oil, rape seed oil, sunflower oil, safflower oil, corn oil, mineral oil, coconut oil, linseed oil, olive oil, sesame seed oil, animal fats, frying oil waste, sewage sludge, and the like.
- FIG. 2 illustrates an exemplary method 200 of producing ethyl esters from free fatty acids according to various embodiments.
- the free fatty acids may be extracted from algal impurities or other impurities using a non-polar solvent.
- non-polar solvents include hexane, cyclohexane, heptane, d-limonene, naphtha, xylene, toluene, pentane, cyclopentane, benzene, 1,4-dioxane, chloroform, diethyl ether, dichloromethane, tetrahydrofuran, and methyl acetate.
- the algal oil containing free fatty acids may be contacted with the non-polar solvent to form a first mixture.
- the algal oil may comprise approximately 3 percent to approximately 15 percent by weight of the first mixture.
- the free fatty acids may dissolve in the non-polar solvent.
- the algal impurities in the algal oil may not dissolve in the non-polar solvent. According to various embodiments, an additional step (not shown in FIG. 2 ) may occur after step 205 to remove these impurities. Filtration or any other technique known in the art may be used to remove the impurities.
- one or more acid and one or more alcohols may be added to the first mixture to form a second mixture (step 210 ).
- the acid and the alcohol may be individually added to the first mixture, or may be first premixed before adding to the first mixture.
- the acid may be a mineral acid or mixture of mineral acids.
- mineral acids are sulfuric acid, hydrochloric acid, nitric acid, perchloric acid, hydrobromic acid, boron trifluoride, hydroiodic acid, and mixtures thereof.
- Non-limiting examples of alcohols are methanol, ethanol, propanol, butanol, pentanol, and mixtures thereof.
- composition of the second mixtures may comprise approximately 0.25 percent to 5 percent by weight acid and approximately 3 percent to 20 percent alcohol by weight.
- the second mixture may also contain water.
- the water may be originally present in any of the ingredients of the second mixture and may also be formed as shown above in Equation 1.
- the water content of the second mixture may range from approximately 0.1 percent to 10 percent by weight.
- the second mixture may then be agitated and heated to a desired reaction temperature (step 215 ).
- the reaction may produce a two-phase system in which one of the phases is an aqueous phase according to various embodiments. Agitating the mixture may facilitate the mass transfer between the first mixture and the second mixture.
- the second mixture may be heated to approximately 50° C. to 100° C., and the reaction time may range from approximately several minutes to several hours to allow the reaction to proceed to the desired completion of amount of conversion (step 220 ). In certain embodiments, the reaction time may be approximately one hour.
- the agitation may be stopped to facilitate separation of the aqueous phase.
- the reaction time may be further extended to promote further conversion (step 230 ) and then the aqueous layer may be removed (step 235 ).
- the aqueous layer may be removed (step 240 ) and then the reaction is allowed to proceed further (step 245 ).
- the aqueous layer may be removed by decanting after stopping the agitation and allowing the phases to separate according to various embodiments.
- any method of separation of the phases known in the art may be used, such as using a centrifuge or an extractor.
- the phase separation may occur while the second mixture is being agitated or after agitation is stopped.
- performing the method 200 in the non-polar solvent in the presence of the acid promotes the formation of the two-phase mixture, comprising a solvent phase and an aqueous phase.
- the solvent phase preferentially contains the free fatty acid, the alcohol, and a catalytic amount of the acid.
- the aqueous phase may preferentially contain the water and the remaining acid and alcohol.
- the aqueous phase acts to pull the water out of the solvent phase (the phase in which the reaction in Equation 1 above is predominantly occurring) and into the aqueous phase.
- the water may be originally present in the components of the second mixture or may be formed as a product of the reaction as shown in Equation 1.
- the presence of water in the reaction mixture will tend to move the equilibrium of the system more towards re-forming the free fatty acids and away from producing ethyl esters.
- the reaction may be allowed to proceed to a surprisingly and unexpectedly higher conversion rate than would be predicted in a single phase system.
- conversions of approximately 98 percent of the free fatty acid to ethyl esters have been achieved.
- Further conversion of the free fatty acids up to approximately 99.5 percent or more may be achieved by removing the aqueous phase when the reaction is near equilibrium and allowing additional reaction time.
- a fatty acid is a carboxylic acid with a long aliphatic tail (chain), which is either saturated or unsaturated. Most naturally occurring fatty acids have a chain of an even number of carbon atoms, from 4 to 28. Saturated fatty acids have no double bonds between carbon atoms. Unsaturated fatty acids have one or more double bonds between carbon atoms. When counting from the terminal methyl carbon toward the carbonyl carbon on an unsaturated fatty acid, the first double bond signifies the omega double bond, such as observed in omega 3, omega 6, or omega 7 fatty acids.
- Palmitoleic acid is an omega-7 monounsaturated fatty acid with a 16-carbon chain with one double bond, denoted as C16:1 n7. A beneficial fatty acid, it has been shown to suppress inflammation. Dietary sources of omega-7 are found in animal and plant sources, including sea buckthorn berries, macadamia nuts, cold water fish and dairy fat. These sources, however, are not concentrated and/or purified sources of POA and often contain a mixed fatty acid profile of saturated and polyunsaturated fats.
- algal omega 7 compositions may comprise by dry weight from about approximately 10% to about approximately 99% palmitoleic acid.
- Such algal compositions may also include (either individually or any combination of) by dry weight: from about approximately 0% to about approximately 20% saturated fatty acids; from about approximately 0% to about approximately 10% arachidonic acid; substantially no (i.e. less than approximately 0.5%) docosahexaenoic acid; and/or from about approximately 0% to about approximately 10% eicosapentaenoic acid.
- the various exemplary algal omega 7 compositions may further be in ethyl ester form.
- ethyl esters are derived by reacting free fatty acids with ethanol. Called esterification, the resulting ethyl ester allows for the fractional distillation (concentration) of the long chain fatty acids at lower temperatures. This step allows for the selective concentration of the fatty acids to levels greater than found in nature.
- Eicosapentaenoic acid is an omega-3 fatty acid with a 20-carbon chain with five double bonds, denoted as 20:5 n3.
- EPA is a polyunsaturated fatty acid that acts as a precursor to certain eicosanoids.
- Sources of EPA include oily fish (fish oils), algal oil, egg oil, squid oil, some plant oils such as that found in seaweed. While the fish do not naturally produce EPA, they obtained it through algae food sources.
- Various exemplary algal omega 3 compositions may comprise by dry weight from about approximately 10% to about approximately 99% eicosapentaenoic acid. Such algal compositions may also comprise by dry weight from about approximately 0% to about 99% other fatty acids.
- An exemplary computing system may be used to implement various embodiments of the systems and methods disclosed herein.
- the computing system may include one or more processors and memory.
- Main memory stores, in part, instructions and data for execution by a processor to cause the computing system to control the operation of the various elements in the systems described herein to provide the functionality of certain embodiments.
- Main memory may include a number of memories including a main random access memory (RAM) for storage of instructions and data during program execution and a read only memory (ROM) in which fixed instructions are stored.
- Main memory may store executable code when in operation.
- the system further may include a mass storage device, portable storage medium drive(s), output devices, user input devices, a graphics display, and peripheral devices.
- the components may be connected via a single bus. Alternatively, the components may be connected via multiple buses.
- Processor unit and main memory may be connected via a local microprocessor bus, and the mass storage device, peripheral device(s), portable storage device, and display system may be connected via one or more input/output (I/O) buses.
- Mass storage device which may be implemented with a magnetic disk drive or an optical disk drive, may be a non-volatile storage device for storing data and instructions for use by the processor unit. Mass storage device may store the system software for implementing various embodiments of the disclosed systems and methods for purposes of loading that software into the main memory.
- Portable storage devices may operate in conjunction with a portable non-volatile storage medium, such as a floppy disk, compact disk or Digital video disc, to input and output data and code to and from the computing system.
- Input devices may provide a portion of a user interface.
- Input devices may include an alpha-numeric keypad, such as a keyboard, for inputting alpha-numeric and other information, or a pointing device, such as a mouse, a trackball, stylus, or cursor direction keys.
- the term input device is intended to include all possible types of devices and ways to input information into the computing system.
- the system may include output devices. Suitable output devices include speakers, printers, network interfaces, and monitors.
- Display system may include a liquid crystal display (LCD) or other suitable display device.
- LCD liquid crystal display
- Display system may receive textual and graphical information, and processes the information for output to the display device.
- output device is intended to include all possible types of devices and ways to output information from the computing system to the user or to another machine or computing system.
- Peripherals may include any type of computer support device to add additional functionality to the computing system.
- Peripheral device(s) may include a modem or a router or other type of component to provide an interface to a communication network.
- the communication network may comprise many interconnected computing systems and communication links.
- the communication links may be wireline links, optical links, wireless links, or any other mechanisms for communication of information.
- the components contained in the computing system may be those typically found in computing systems that may be suitable for use with embodiments of the systems and methods disclosed herein and are intended to represent a broad category of such computing components that are well known in the art.
- the computing system may be a personal computer, hand held computing device, telephone, mobile computing device, workstation, server, minicomputer, mainframe computer, or any other computing device.
- the computer may also include different bus configurations, networked platforms, multi-processor platforms, etc.
Abstract
Various embodiments of the present invention include systems and methods for converting free fatty acids to ethyl esters. An exemplary method may comprise contacting the free fatty acid with a non-polar solvent. A mineral acid and an alcohol may then be added to form a two-phase mixture. An aqueous phase my subsequently be removed from the mixture. The processes and methods may be used in the manufacture of supplements, pharmaceuticals, cosmetic and beauty products, feedstocks, and the like.
Description
- The present application claims the benefit and priority of U.S. Provisional Patent Application Ser. No. 61/800,114 filed on Mar. 15, 2013 and titled “(EPA) Algal Biomass and Oil Compositions and Impact on Health,” which is hereby incorporated by reference.
- The present application claims the benefit and priority of U.S. Provisional Patent Application Ser. No. 61/800,029 filed on Mar. 15, 2013 and titled “Microalga Species and Industrial Applications,” which is hereby incorporated by reference.
- The present application is related to U.S. Non-Provisional patent application Ser. No. ______, filed on ______ concurrently with the present application and titled “Algal Omega 7 Compositions,” which is hereby incorporated by reference.
- The present application is related to U.S. Non-Provisional patent application Ser. No. ______ filed on ______ concurrently with the present application and titled Algal Oil Compositions,” which is hereby incorporated by reference.
- The present application is related to U.S. Non-Provisional patent application Ser. No. ______, filed on ______ concurrently with the present application and titled “Algal Omega 7 and Algal Omega 3 Blend Compositions,” which is hereby incorporated by reference.
- The present application is related to U.S. Non-Provisional patent application Ser. No. ______ filed on ______ concurrently with the present application and titled “Compositions and Methods for Utilization of Algal Compounds,” which is hereby incorporated by reference.
- The present invention is directed to systems and methods for producing ethyl esters from free fatty acids.
- Various embodiments of the present invention include systems and methods for converting free fatty acids into ethyl esters. An exemplary method may comprise contacting the free fatty acid with a non-polar solvent. A mineral acid and an alcohol may then be added to form a two-phase mixture. An aqueous phase may subsequently be removed from the mixture.
-
FIG. 1 is general flow chart of an exemplary method for producing ethyl esters. -
FIG. 2 is a flow chart of an exemplary method for converting free fatty acids to ethyl esters. - Various embodiments of the present invention are directed to processes and methods for converting free fatty acids to ethyl esters. An exemplary method may comprise contacting the free fatty acid with a non-polar solvent to form a first mixture. An acid and an alcohol may then be added to form a second mixture. The second mixture may be heated and agitated to form a two-phase mixture, and an aqueous phase may be removed from the two-phase mixture. The processes and methods may be used in the manufacture of supplements, pharmaceuticals, cosmetic and beauty products, feedstocks, and the like.
- Lipids are a broad class of chemical compounds that may be defined as “fatty acids and their derivatives, and the substances related biosynthetically or functionally to these compounds” [W. W. Christie, Gas Chromatography and Lipids: A Practical Guide (1989), p. 5]. Most lipids are soluble in organic solvents, but many are insoluble in water; however, given the diverse nature of lipids, some compounds regarded as lipids may also be soluble in water. Organic solvents in which lipids are soluble are generally non-polar solvents and may include pentane, cyclopentane, hexane, cyclohexane, benzene, toluene, 1,4-dioxane, chloroform, diethyl ether, methylene chloride, ethyl acetate, d-limonene, heptane, naphtha, and xylene, among others. Higher melting point lipids are typically solids at room temperature and are broadly classified as fats or waxes. Lipids with lower melting points are typical liquids at room temperature and are broadly classified as oils. Free fatty acids may be defined as non-esterified fatty acids.
- Comprehensive classification of lipids is difficult because of their diverse nature. One classification system for biological lipids is based on the biochemical subunits from which the lipids originate. This system provides for various general categories of biological lipids, including fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, saccharolipids, sterol lipids, and glycolipids.
- Fatty acyls (or fatty acids and their conjugates and derivatives) are straight-chain carbon compounds that may be naturally synthesized via condensation of malonyl coenzyme A units by a fatty acid synthase complex. Fatty acyls typically have a carbon chain comprised of 4 to 24 carbon atoms, and often terminate with a carboxyl group (—COOH). Lipids containing fatty acyls can be hydrolyzed into alkali fatty acid salts using basic hydrolysis, a process known as saponification. Fatty acyls may be saturated or unsaturated, and may also include functional groups containing oxygen, nitrogen, sulfur, and halogens. Fatty acyls found in plant tissues commonly have a carbon chain comprised of 14, 16, 18, 20, or 24 carbon atoms.
- Common fatty acyls of plant and animal origin can be divided into three broad categories of saturated fatty acids, monoenoic fatty acids, and polyunsaturated fatty acids. Saturated fatty acids are characterized as having 2 or more carbon atoms in the carbon chain with no double bonds between any of the carbon atoms. Example saturated fatty acids include ethanoic acid, butanoic acid, hexanoic acid, octanoic acid, decanoic acid, dodecanoic acid, tetradecanoic acid, hexadecanoic acid, octadecanoic acid, eicosanoic acid, docosanoic acid, and tetracosanoic acid. Monoenoic fatty acids are characterized as having a single carbon-carbon double bond in the carbon chain. The double bond is typically a cis-configuration, although some trans-configuration compounds are known. Example monoenoic fatty acids include cis-9-hexadecenoic acid, cis-6-octadecenoic acid, cis-9-octadecenoic acid, cis-11-octadecenoic acid, cis-13-docosenoic acid, and cis-15-tetracosenoic acid. Polyunsaturated fatty acids are characterized as having two or more carbon-carbon double bonds in the carbon chain. Example polyunsaturated fatty acids include 9,12-octadecadienoic acid, 6,9,12-octadecatrienoic acid, 9,12,15-octadecatrienoic acid, 5,8,11,14-eicosatetraenoic acid, 5,8,11,14,17-eicosapentaenoic acid, and 4,7,10,13,16,19-docosahexanoic acid.
- Glycerolipids may be formed by joining fatty acids to glycerol by ester bonds. The majority of glycerolipids are formed by mono-, di-, or tri-substitution of fatty acids on the glycerol molecule. The most common naturally occurring glycerolipids are of the tri-substituted variety, known as triacylglycerols or triglycerides. Example glycerolipids include monoradylglycerols, monoacylglycerols, monoalkylglycerols, mono-(1Z-alkenyl)-glycerols, diradylglycerols, diacylglycerols, 1-alkyl,2-acylglycerols, 1-acyl,2-alkylglycerols, dialkylglycerols, 1Z-alkenylacylglycerols, di-glycerol tetraethers, di-glycerol tetraether glycans, triradylglycerols, triacylglycerols, alkyldiacylglycerols, dialkylmonoacylglycerols, 1Z-alkenyldiacylglycerols, estolides, glycosylmonoradylglycerols, glycosylmonoacylglycerols, glycosylmonoalkylglycerols, glycosyldiradylglycerols, glycosyldiacylglycerols, glycosylalkylacylglycerols, and glycosyldialkylglycerols.
- Glycerophospholipids (or simply phospholipids) may be characterized by fatty acids linked through an ester oxygen to the first and second carbon atoms of the glycerol molecule, with a phosphate functional group ester-linked to the third carbon atom to the glycerol molecule. Other functional groups may also be linked to the phosphate functional group. In plant and animal cells, glycerophospholipids may serve as structural components of the cell membrane. Example glycerophospholipids include phosphatidyl choline (lecithin), phosphatidyl ethanolamine (cephalin), phosphatidyl inositol, phosphatidylserine, bisphosphatidylglycerol (cardiolipin), glycerophosphocholines, diacylglycerophosphocholines, 1-alkyl,2-acylglycerophosphocholines, 1-acyl,2-alkylglycerophosphocholines, 1Z-alkenyl,2-acylglycerophosphocholines, dialkylglycerophosphocholines, monoacylglycerophosphocholines, monoalkylglycerophosphocholines, 1Z-alkenylglycerophosphocholines, glycerophosphoethanolamines, diacylglycerophosphoethanolamines, 1-alkyl,2-acylglycerophosphoethanolamines, 1-acyl,2-alkylglycerophosphoethanolamines, 1Z-alkenyl,2-acylglycerophosphoethanolamines, dialkylglycerophosphoethanolamines, monoacylglycerophosphoethanolamines, monoalkylglycerophosphoethanolamines, 1Z-alkenylglycerophosphoethanolamines, glycerophosphoserines, diacylglycerophosphoserines, 1-alkyl,2-acylglycerophosphoserines, 1Z-alkenyl,2-acylglycerophosphoserines, dialkylglycerophosphoserines, monoacylglycerophosphoserines, monoalkylglycerophosphoserines, 1Z-alkenylglycerophosphoserines, glycerophosphoglycerols, diacylglycerophosphoglycerols, 1-alkyl,2-acylglycerophosphoglycerols, 1-acyl,2-alkylglycerophosphoglycerols, 1Z-alkenyl,2-acylglycerophosphoglycerols, dialkylglycerophosphoglycerols, monoacylglycerophosphoglycerols, monoalkylglycerophosphoglycerols, 1Z-alkenylglycerophosphoglycerols, diacylglycerophosphodiradylglycerols, diacylglycerophosphomonoradylglycerols, monoacylglycerophosphomonoradylglycerols, glycerophosphoglycerophosphates, diacylglycerophosphoglycerophosphates, 1-alkyl,2-acylglycerophosphoglycerophosphates, 1Z-alkenyl,2-acylglycerophosphoglycerophosphates, dialkylglycerophosphoglycerophosphates, monoacylglycerophosphoglycerophosphates, monoalkylglycerophosphoglycerophosphates, 1Z-alkenylglycerophosphoglycerophosphates, glycerophosphoinositols, diacylglycerophosphoinositols, 1-alkyl,2-acylglycerophosphoinositols, 1Z-alkenyl,2-acylglycerophosphoinositols, dialkylglycerophosphoinositols, monoacylglycerophosphoinositols, onoalkylglycerophosphoinositols, 1Z-alkenylglycerophosphoinositols, glycerophosphoinositol monophosphates, diacylglycerophosphoinositol monophosphates, 1-alkyl,2-acylglycerophosphoinositol monophosphates, 1Z-alkenyl,2-acylglycerophosphoinositol monophosphates, dialkylglycerophosphoinositol monophosphates, monoacylglycerophosphoinositol monophosphates, monoalkylglycerophosphoinositol monophosphates, 1Z-alkenylglycerophosphoinositol monophosphates, glycerophosphoinositol bisphosphates, diacylglycerophosphoinositol bisphosphates, 1-alkyl,2-acylglycerophosphoinositol bisphosphates, 1Z-alkenyl,2-acylglycerophosphoinositol bisphosphates, monoacylglycerophosphoinositol bisphosphates, onoalkylglycerophosphoinositol bisphosphates, 1Z-alkenylglycerophosphoinositol bisphosphates, glycerophosphoinositol trisphosphates, diacylglycerophosphoinositol trisphosphates, 1-alkyl,2-acylglycerophosphoinositol trisphosphates, 1Z-alkenyl,2-acylglycerophosphoinositol trisphosphates, monoacylglycerophosphoinositol trisphosphates, monoalkylglycerophosphoinositol trisphosphates, 1Z-alkenylglycerophosphoinositol trisphosphates, glycerophosphates, diacylglycerophosphates, 1-alkyl,2-acylglycerophosphates, 1Z-alkenyl,2-acylglycerophosphates, dialkylglycerophosphates, monoacylglycerophosphates, monoalkylglycerophosphates, 1Z-alkenylglycerophosphates, glyceropyrophosphates, diacylglyceropyrophosphates, monoacylglyceropyrophosphates, glycerophosphoglycerophosphoglycerols, diacylglycerophosphoglycerophosphodiradylglycerols, diacylglycerophosphoglycerophosphomonoradylglycerols, 1-alkyl,2-acylglycerophosphoglycerophosphodiradylglycerols, 1-alkyl,2-acylglycerophosphoglycerophosphomonoradylglycerols, 1Z-alkenyl,2-acylglycerophosphoglycerophosphodiradylglycerols, 1Z-alkenyl,2-acylglycerophosphoglycerophosphomonoradylglycerols, dialkylglycerophosphoglycerophosphodiradylglycerols, dialkylglycerophosphoglycerophosphomonoradylglycerols, monoacylglycerophosphoglycerophosphomonoradylglycerols, monoalkylglycerophosphoglycerophosphodiradylglycerols, monoalkylglycerophosphoglycerophosphomonoradylglycerols, 1Z-alkenylglycerophosphoglycerophosphodiradylglycerols, 1Z-alkenylglycerophosphoglycerophosphomonoradylglycerols, CDP-glycerols, CDP-diacylglycerols, CDP-1-alkyl,2-acylglycerols, CDP-1Z-alkenyl,2-acylglycerols, CDP-dialkylglycerols, CDP-monoacylglycerols, CDP-monoalkylglycerols, CDP-1Z-alkenylglycerols, glycosylglycerophospholipids, diacylglycosylglycerophospholipids, 1-alkyl,2-acylglycosylglycerophospholipids, 1Z-alkenyl,2-acylglycosylglycerophospholipids, dialkylglycosylglycerophospholipids, monoacylglycosylglycerophospholipids, monoalkylglycosylglycerophospholipids, 1Z-alkenylglycosylglycerophospholipids, glycerophosphoinositolglycans, diacylglycerophosphoinositolglycans, 1-alkyl,2-acylglycerophosphoinositolglycans, 1Z-alkenyl,2-acylglycerophosphoinositolglycans, monoacylglycerophosphoinositolglycans, monoalkylglycerophosphoinositolglycans, 1Z-alkenylglycerophosphoinositolglycans, glycerophosphonocholines, diacylglycerophosphonocholines, 1-alkyl,2-acylglycerophosphonocholines, 1Z-alkenyl,2-acylglycerophosphonocholines, dialkylglycerophosphonocholines, monoacylglycerophosphonocholines, monoalkylglycerophosphonocholines, 1Z-alkenylglycerophosphonocholines, glycerophosphonoethanolamines, diacylglycerophosphonoethanolamines, 1-alkyl,2-acylglycerophosphonoethanolamines, 1Z-alkenyl,2-acylglycerophosphonoethanolamines, dialkylglycerophosphonoethanolamines, monoacylglycerophosphonoethanolamines, monoalkylglycerophosphonoethanolamines, 1Z-alkenylglycerophosphonoethanolamines, di-glycerol tetraether phospholipids (caldarchaeols), glycerol-nonitol tetraether phospholipids, oxidized glycerophospholipids, oxidized glycerophosphocholines, and oxidized glycerophosphoethanolamines.
- Sphingolipids may be characterized by a long-chain base (typically 12 to 26 carbon atoms) linked by an amide bond to a fatty acid and via a terminal hydroxyl group to complex carbohydrates or phosphorous functional groups. These lipids play important roles in signal transmission between cells and cell recognition. Example sphingolipids include sphing-4-enines (sphingosines), sphinganines, 4-hydroxysphinganines (phytosphingosines), sphingoid base homologs and variants, sphingoid base 1-phosphates, lysosphingomyelins and lysoglycosphingolipids, N-methylated sphingoid bases, sphingoid base analogs, ceramides, N-acylsphingosines (ceramides), N-acylsphinganines (dihydroceramides), N-acyl-4-hydroxysphinganines (phytoceramides), acylceramides, ceramide 1-phosphates, phosphosphingolipids, ceramide phosphocholines (sphingomyelins), ceramide phosphoethanolamines, ceramide phosphoinositols, phosphonosphingolipids, neutral glycosphingolipids, simple Glc series, GalNAcβ1-3Galα1-4Galβ1-4Glc-(globo series), GalNAcβ1-4Galβ1-4Glc-(ganglio series), Galβ1-3GlcNAcβ1-3Galβ1-4Glc-(lacto series), Galβ1-4GlcNAcβ1-3Galβ1-4Glc-(neolacto series), GalNAcβ1-3Galα1-3Galβ1-4Glc-(isoglobo series), GlcNAcβ1-2Manα1-3Manβ1-4Glc-(mollu series), GalNAcβ1-4GlcNAcβ1-3Manβ1-4Glc-(arthro series), acidic glycosphingolipids, gangliosides, sulfoglycosphingolipids (sulfatides), glucuronosphingolipids, phosphoglycosphingolipids, basic glycosphingolipids, amphoteric glycosphingolipids, and arsenosphingolipids.
- Saccharolipids may be comprised of fatty acids linked directly to a sugar backbone. Typically, a monosaccharide takes the place of the glycerol molecule that forms the backbone of other lipids such as glycerolipids and glycerophospholipids. Saccharolipids play a role in the bilayer structure of cell membranes. Example saccharolipids include acylaminosugars, monoacylaminosugars, diacylaminosugars, triacylaminosugars, tetraacylaminosugars, pentaacylaminosugars, hexaacylaminosugars, heptaacylaminosugars, acylaminosugar glycans, acyltrehaloses, and acyltrehalose glycans.
- Glycoglycerolipids may be comprised of fatty acids linked through an ester oxygen to the first and second carbons of a glycerol molecule, with a carbohydrate functional group ester-linked to the third carbon atom. The carbohydrate functional group may include one or more sugar monomers. Other functional groups may also be linked to the carbohydrate functional group. Example glycoglycerolipids include monogalactosyldiacylglycerols, digalactosyldiacylglycerols, trigalactosyldiacylglycerols, tetragalactosyldiacylglycerols, polygalactosyldiacylglycerols, monoglucosyldiacylglycerols, diglucosyldiacylglycerols, monogalactosylmonoacylglycerols, digalactosylmonoacylglycerols, sulfoquinovosyldiacylglycerols, acylsulfoquinovosyldiacylglycerols, acylgalactosylglucossyldiacylglycerols, kojibiosyldiaacylglycerols, galactofuranosyldiacylglycerols, galactopyranosyldiacylglycerols, 1,2-diacyl-3-O-a-D-glucuronyl-sn-glycerols, glucosylglucuronyldiacylglycerols, galacturonyldiacylglycerols, polyglucosyldiacylglycerols, and monoglucosyldiacylglycerols.
- Sterol esters may be characterized as comprising alcohols sharing a fused four-ring steroid structure ester-linked to one or more fatty acyls. Examples include cholesteryl esters, campesterol esters, stigmasterol esters, sitosterol esters, avenasterol esters, fucosterol esters, isofucosterol esters, and ethylcholesteryl esters.
-
FIG. 1 illustrates a general process for converting free fatty acids into ethyl esters. Free fatty acids may be obtained from a variety of sources. For example, crude algal oil obtained from various algae species may be converted to free fatty acids in an aqueous system (step 105). The crude algal oil is typically a mixture of oils, waxes, chlorophyll, and other species that originally supported the functioning of the algae plant. The free fatty acids may be extracted from other algal impurities. Atstep 110, the free fatty acids may be mixed with a mineral acid and an alcohol to impart a phase separation of the mixture. An esterification reaction may occur (step 115) to convert the free fatty acids to the ethyl ester form. The ethyl esters may then be isolated from the mixture (step 120). - Esterification is the chemical process of producing esters. Most commonly, esters are formed from a fatty acid and an alcohol. For example, carboxylic acid (a fatty acid) may react with ethanol in the presence of an acid catalyst to produce ethyl esters and water according to Equation 1.
-
RCOOH+CH3CH2OH→RCOOCH2CH3+H2O Equation 1 - The reaction of Equation 1 is also reversible in that the water formed will react with the ethyl ester in the presence of an acid to produce free fatty acids. This reverse reaction has a higher propensity to occur than the esterification reaction, meaning that the produced water should be removed from the reaction mixture to achieve higher conversion of the free fatty acid. Without removal of the water, a reaction mixture of 10 percent water and 90 percent ethanol on a molar basis may produce a mixture that is approximately 30 percent free fatty acid and 70 percent ethyl ester on a molar basis (that is, about a 70 percent conversion).
- In various embodiments, various algae species may be the source of the crude algal oil from which the free fatty acids may be obtained. Algae are mostly aquatic photosynthetic organisms that range from microscopic flagellate to giant kelp. Algae may be loosely grouped into seven categories: Euglenophyta (euglenoids), Chrysophyta (golden-brown algae), Pyrrophyta (fire algae), Dinoflagellata, Chlorophyta (green algae), Rhodophyta (red algae), Paeophyta (brown algae), and Xanthophyta (yellow-green algae). Lipid extracted from any algae genus may be used in the various embodiments of the present invention, including Amphora, Anabaena, Anikstrodesmis, Botryococcus, Chaetoceros, Chlorella, Chlorococcum, Cyclotella, Cylindrotheca, Dunaliella, Emiliania, Euglena, Glossomastix, Haematococcus, Isochrysis, Monochrysis, Monoraphidium, Nannochloris, Nannochloropsis, Navicula, Nephrochloris, Nephroselmis, Nitzschia, Nodularia, Nostoc, Oochromonas, Oocystis, Oscillatoria, Pavlova, Phaeodactylum, Picochloris, Platymonas, Pleurochrysis, Porphyra, Pseudoanabaena, Pyramimonas, Scenedesmus, Stichococcus, Synechococcus, Synechocystis, Tetraselmis, Thalassiosira, and Trichodesmium.
- Additionally, free fatty acids from non-algae sources, such as plant oils and animal oils may also be used in various embodiments, as may various petroleum-based products and synthetic oils. Non-limiting examples of sources of non-algae free fatty acids include fish oil, tung oil, colza oil, soy bean oil, corn oil, peanut oil, palm oil, rape seed oil, sunflower oil, safflower oil, corn oil, mineral oil, coconut oil, linseed oil, olive oil, sesame seed oil, animal fats, frying oil waste, sewage sludge, and the like.
-
FIG. 2 illustrates anexemplary method 200 of producing ethyl esters from free fatty acids according to various embodiments. Atstep 205, the free fatty acids may be extracted from algal impurities or other impurities using a non-polar solvent. Non-limiting examples of non-polar solvents include hexane, cyclohexane, heptane, d-limonene, naphtha, xylene, toluene, pentane, cyclopentane, benzene, 1,4-dioxane, chloroform, diethyl ether, dichloromethane, tetrahydrofuran, and methyl acetate. In various embodiments, the algal oil containing free fatty acids may be contacted with the non-polar solvent to form a first mixture. The algal oil may comprise approximately 3 percent to approximately 15 percent by weight of the first mixture. The free fatty acids may dissolve in the non-polar solvent. - The algal impurities in the algal oil may not dissolve in the non-polar solvent. According to various embodiments, an additional step (not shown in
FIG. 2 ) may occur afterstep 205 to remove these impurities. Filtration or any other technique known in the art may be used to remove the impurities. - In various embodiments, one or more acid and one or more alcohols may be added to the first mixture to form a second mixture (step 210). The acid and the alcohol may be individually added to the first mixture, or may be first premixed before adding to the first mixture. In various embodiments, the acid may be a mineral acid or mixture of mineral acids. Non-limiting examples of mineral acids are sulfuric acid, hydrochloric acid, nitric acid, perchloric acid, hydrobromic acid, boron trifluoride, hydroiodic acid, and mixtures thereof. Non-limiting examples of alcohols are methanol, ethanol, propanol, butanol, pentanol, and mixtures thereof.
- The composition of the second mixtures according to various embodiments may comprise approximately 0.25 percent to 5 percent by weight acid and approximately 3 percent to 20 percent alcohol by weight. The second mixture may also contain water. The water may be originally present in any of the ingredients of the second mixture and may also be formed as shown above in Equation 1. In various embodiments, the water content of the second mixture may range from approximately 0.1 percent to 10 percent by weight.
- The second mixture may then be agitated and heated to a desired reaction temperature (step 215). The reaction may produce a two-phase system in which one of the phases is an aqueous phase according to various embodiments. Agitating the mixture may facilitate the mass transfer between the first mixture and the second mixture. In various embodiments, the second mixture may be heated to approximately 50° C. to 100° C., and the reaction time may range from approximately several minutes to several hours to allow the reaction to proceed to the desired completion of amount of conversion (step 220). In certain embodiments, the reaction time may be approximately one hour.
- At
step 225, the agitation may be stopped to facilitate separation of the aqueous phase. In various embodiments, the reaction time may be further extended to promote further conversion (step 230) and then the aqueous layer may be removed (step 235). Alternatively, the aqueous layer may be removed (step 240) and then the reaction is allowed to proceed further (step 245). - The aqueous layer may be removed by decanting after stopping the agitation and allowing the phases to separate according to various embodiments. However, any method of separation of the phases known in the art may be used, such as using a centrifuge or an extractor. The phase separation may occur while the second mixture is being agitated or after agitation is stopped.
- In various embodiments, performing the
method 200 in the non-polar solvent in the presence of the acid promotes the formation of the two-phase mixture, comprising a solvent phase and an aqueous phase. The solvent phase preferentially contains the free fatty acid, the alcohol, and a catalytic amount of the acid. The aqueous phase may preferentially contain the water and the remaining acid and alcohol. According to various embodiments, the aqueous phase acts to pull the water out of the solvent phase (the phase in which the reaction in Equation 1 above is predominantly occurring) and into the aqueous phase. The water may be originally present in the components of the second mixture or may be formed as a product of the reaction as shown in Equation 1. As described previously, the presence of water in the reaction mixture will tend to move the equilibrium of the system more towards re-forming the free fatty acids and away from producing ethyl esters. Thus, by removing the water from the solvent phase, the reaction may be allowed to proceed to a surprisingly and unexpectedly higher conversion rate than would be predicted in a single phase system. In various embodiments, conversions of approximately 98 percent of the free fatty acid to ethyl esters have been achieved. Further conversion of the free fatty acids up to approximately 99.5 percent or more may be achieved by removing the aqueous phase when the reaction is near equilibrium and allowing additional reaction time. - The methods described herein may be used to produce ethyl ester forms of free fatty acid. A fatty acid is a carboxylic acid with a long aliphatic tail (chain), which is either saturated or unsaturated. Most naturally occurring fatty acids have a chain of an even number of carbon atoms, from 4 to 28. Saturated fatty acids have no double bonds between carbon atoms. Unsaturated fatty acids have one or more double bonds between carbon atoms. When counting from the terminal methyl carbon toward the carbonyl carbon on an unsaturated fatty acid, the first double bond signifies the omega double bond, such as observed in omega 3, omega 6, or omega 7 fatty acids.
- Palmitoleic acid (POA) is an omega-7 monounsaturated fatty acid with a 16-carbon chain with one double bond, denoted as C16:1 n7. A beneficial fatty acid, it has been shown to suppress inflammation. Dietary sources of omega-7 are found in animal and plant sources, including sea buckthorn berries, macadamia nuts, cold water fish and dairy fat. These sources, however, are not concentrated and/or purified sources of POA and often contain a mixed fatty acid profile of saturated and polyunsaturated fats.
- Various exemplary algal omega 7 compositions may comprise by dry weight from about approximately 10% to about approximately 99% palmitoleic acid. Such algal compositions may also include (either individually or any combination of) by dry weight: from about approximately 0% to about approximately 20% saturated fatty acids; from about approximately 0% to about approximately 10% arachidonic acid; substantially no (i.e. less than approximately 0.5%) docosahexaenoic acid; and/or from about approximately 0% to about approximately 10% eicosapentaenoic acid.
- Additionally, the various exemplary algal omega 7 compositions may further be in ethyl ester form. Such ethyl esters are derived by reacting free fatty acids with ethanol. Called esterification, the resulting ethyl ester allows for the fractional distillation (concentration) of the long chain fatty acids at lower temperatures. This step allows for the selective concentration of the fatty acids to levels greater than found in nature.
- Eicosapentaenoic acid (EPA) is an omega-3 fatty acid with a 20-carbon chain with five double bonds, denoted as 20:5 n3. EPA is a polyunsaturated fatty acid that acts as a precursor to certain eicosanoids. Sources of EPA include oily fish (fish oils), algal oil, egg oil, squid oil, some plant oils such as that found in seaweed. While the fish do not naturally produce EPA, they obtained it through algae food sources. Various exemplary algal omega 3 compositions may comprise by dry weight from about approximately 10% to about approximately 99% eicosapentaenoic acid. Such algal compositions may also comprise by dry weight from about approximately 0% to about 99% other fatty acids.
- An exemplary computing system may be used to implement various embodiments of the systems and methods disclosed herein. The computing system may include one or more processors and memory. Main memory stores, in part, instructions and data for execution by a processor to cause the computing system to control the operation of the various elements in the systems described herein to provide the functionality of certain embodiments. Main memory may include a number of memories including a main random access memory (RAM) for storage of instructions and data during program execution and a read only memory (ROM) in which fixed instructions are stored. Main memory may store executable code when in operation. The system further may include a mass storage device, portable storage medium drive(s), output devices, user input devices, a graphics display, and peripheral devices. The components may be connected via a single bus. Alternatively, the components may be connected via multiple buses. The components may be connected through one or more data transport means. Processor unit and main memory may be connected via a local microprocessor bus, and the mass storage device, peripheral device(s), portable storage device, and display system may be connected via one or more input/output (I/O) buses. Mass storage device, which may be implemented with a magnetic disk drive or an optical disk drive, may be a non-volatile storage device for storing data and instructions for use by the processor unit. Mass storage device may store the system software for implementing various embodiments of the disclosed systems and methods for purposes of loading that software into the main memory. Portable storage devices may operate in conjunction with a portable non-volatile storage medium, such as a floppy disk, compact disk or Digital video disc, to input and output data and code to and from the computing system. The system software for implementing various embodiments of the systems and methods disclosed herein may be stored on such a portable medium and input to the computing system via the portable storage device. Input devices may provide a portion of a user interface. Input devices may include an alpha-numeric keypad, such as a keyboard, for inputting alpha-numeric and other information, or a pointing device, such as a mouse, a trackball, stylus, or cursor direction keys. In general, the term input device is intended to include all possible types of devices and ways to input information into the computing system. Additionally, the system may include output devices. Suitable output devices include speakers, printers, network interfaces, and monitors. Display system may include a liquid crystal display (LCD) or other suitable display device.
- Display system may receive textual and graphical information, and processes the information for output to the display device. In general, use of the term output device is intended to include all possible types of devices and ways to output information from the computing system to the user or to another machine or computing system. Peripherals may include any type of computer support device to add additional functionality to the computing system. Peripheral device(s) may include a modem or a router or other type of component to provide an interface to a communication network. The communication network may comprise many interconnected computing systems and communication links. The communication links may be wireline links, optical links, wireless links, or any other mechanisms for communication of information. The components contained in the computing system may be those typically found in computing systems that may be suitable for use with embodiments of the systems and methods disclosed herein and are intended to represent a broad category of such computing components that are well known in the art. Thus, the computing system may be a personal computer, hand held computing device, telephone, mobile computing device, workstation, server, minicomputer, mainframe computer, or any other computing device. The computer may also include different bus configurations, networked platforms, multi-processor platforms, etc.
- Various operating systems may be used including Unix, Linux, Windows, Macintosh OS, Palm OS, MS-DOS, MINIX, VMS, OS/2, and other suitable operating systems. Due to the ever changing nature of computers and networks, the description of the computing system is intended only as a specific example for purposes of describing embodiments. Many other configurations of the computing system are possible having more or less components.
- As used herein, the terms “having”, “containing”, “including”, “comprising”, and the like are open ended terms that indicate the presence of stated elements or features, but do not preclude additional elements or features. The articles “a”, “an” and “the” are intended to include the plural as well as the singular, unless the context clearly indicates otherwise.
- The above description is illustrative and not restrictive. Many variations of the invention will become apparent to those of skill in the art upon review of this disclosure. The scope of the invention should, therefore, be determined not with reference to the above description, but instead should be determined with reference to the appended claims along with their full scope of equivalents.
- While the present invention has been described in connection with a series of preferred embodiments, these descriptions are not intended to limit the scope of the invention to the particular forms set forth herein. It will be further understood that the methods of the invention are not necessarily limited to the discrete steps or the order of the steps described. To the contrary, the present descriptions are intended to cover such alternatives, modifications, and equivalents as may be included within the spirit and scope of the invention as defined by the appended claims and otherwise appreciated by one of ordinary skill in the art.
Claims (30)
1. A method for converting a free fatty acid into an ethyl ester form of the free fatty acid, comprising:
contacting the free fatty acid with a non-polar solvent to form a first mixture;
adding a mineral acid and an alcohol to the first mixture to form a second mixture;
heating and agitating the second mixture to form a two-phase mixture; and
removing an aqueous phase from the two-phase mixture.
2. The method of claim 1 , the non-polar solvent further comprising hexane, cyclohexane, heptane, d-limonene, naphtha, xylene, toluene, pentane, cyclopentane, benzene, 1,4-dioxane, chloroform, diethyl ether, dichloromethane, methyl acetate, and mixtures thereof.
3. The method of claim 1 , the non-polar solvent further comprising heptane.
4. The method of claim 1 , the free fatty acid representing by weight from approximately 3% to 15% of the first mixture.
5. The method of claim 1 , the alcohol further comprising methanol, ethanol, propanol, butanol, pentanol, and mixtures thereof.
6. The method of claim 1 , the alcohol further comprising ethanol.
7. The method of claim 6 , the ethanol representing by weight from approximately 3% to 20% of the second mixture.
8. The method of claim 1 , the mineral acid further comprising sulfuric acid, hydrochloric acid, perchloric acid, boron trifluoride, and mixtures thereof.
9. The method of claim 1 , the mineral acid further comprising sulfuric acid.
10. The method of claim 9 , the sulfuric acid representing by weight from approximately 0.4% to 5% of the second mixture.
11. The method of claim 1 , further comprising the adding sulfuric acid and ethanol to the first mixture in presence of water.
12. The method of claim 11 , the water representing by weight from approximately 0.1% to 10% of the second mixture.
13. The method of claim 1 further comprising heating the second mixture to between approximately 50° C. to approximately 100° C. for approximately one hour.
14. The method of claim 1 further comprising stopping the agitating prior to the removing of the aqueous phase.
15. The method of claim 1 further comprising removing the aqueous phase while agitating the second mixture.
16. The method of claim 15 further comprising removing the aqueous phase using a centrifuge.
17. The method of claim 15 further comprising removing the aqueous phase using an extractor.
18. The method of claim 17 further comprising heating and agitating a remaining solution formed by the removing of the aqueous phase.
19. The method of claim 1 further comprising the free fatty acid being produced by an algal genus.
20. The method of claim 19 , further comprising the algal genus comprising one or more of Amphora, Anabaena, Anikstrodesmis, Botryococcus, Chaetoceros, Chlorella, Chlorococcum, Cyclotella, Cylindrotheca, Dunaliella, Emiliania, Euglena, Glossomastix, Haematococcus, Isochrysis, Monochrysis, Monoraphidium, Nannochloris, Nannochloropsis, Navicula, Nephrochloris, Nephroselmis, Nitzschia, Nodularia, Nostoc, Oochromonas, Oocystis, Oscillatoria, Pavlova, Phaeodactylum, Picochloris, Platymonas, Pleurochrysis, Porphyra, Pseudoanabaena, Pyramimonas, Scenedesmus, Stichococcus, Synechococcus, Synechocystis, Tetraselmis, Thalassiosira, and Trichodesmium.
21. The method of claim 1 , further comprising producing a free fatty acid composition comprising by dry weight approximately 10% to approximately 99% C16:1 n7 palmitoleic acid and less than approximately 20% saturated fatty acids.
22. The method of claim 1 , further comprising a free fatty acid composition comprising by dry weight approximately 10% to approximately 99% C20:5 n3 eicosapentaenoic acid and less than approximately 10% saturated fatty acids.
23. A method for converting a free fatty acid into an ethyl ester form of the free fatty acid, comprising:
contacting algal oil containing free-fatty acids with a non-polar solvent to form a first mixture, the algal oil representing by weight from approximately 3% to 15% of the first mixture;
adding sulfuric acid and ethanol to the first mixture to form a second mixture, the sulfuric acid representing by weight from approximately 0.4% to 5% of the second mixture, and the ethanol representing by weight approximately 3% to 30% of the second mixture;
heating and agitating the second mixture to form a two-phase mixture; and
removing an aqueous phase from the two-phase mixture.
24. The method of claim 23 , the non-polar solvent further comprising hexane, cyclohexane, heptane, d-limonene, naphtha, xylene, toluene, pentane, cyclopentane, benzene, 1,4-dioxane, chloroform, diethyl ether, dichloromethane, tetrahydrofuran, methyl acetate, and mixtures thereof.
25. The method of claim 23 further comprising heating the second mixture to between approximately 50° C. to approximately 100° C. for approximately one hour.
26. The method of claim 23 further comprising stopping the agitating prior to the removing of the aqueous phase.
27. The method of claim 23 further comprising removing the aqueous phase using a centrifuge.
28. The method of claim 23 further comprising removing the aqueous phase using an extractor.
29. The method of claim 23 further comprising the free fatty acid being produced by an algal genus.
30. The method of claim 29 , further comprising the algal genus comprising one or more of Amphora, Anabaena, Anikstrodesmis, Botryococcus, Chaetoceros, Chlorella, Chlorococcum, Cyclotella, Cylindrotheca, Dunaliella, Emiliania, Euglena, Glossomastix, Haematococcus, Isochrysis, Monochrysis, Monoraphidium, Nannochloris, Nannochloropsis, Navicula, Nephrochloris, Nephroselmis, Nitzschia, Nodularia, Nostoc, Oochromonas, Oocystis, Oscillatoria, Pavlova, Phaeodactylum, Picochloris, Platymonas, Pleurochrysis, Porphyra, Pseudoanabaena, Pyramimonas, Scenedesmus, Stichococcus, Synechococcus, Synechocystis, Tetraselmis, Thalassiosira, and Trichodesmium.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/025,740 US20140275613A1 (en) | 2013-03-15 | 2013-09-12 | Conversion of free fatty acids to ethyl esters |
US14/025,772 US9445619B2 (en) | 2013-03-15 | 2013-09-12 | Compositions and methods for utilization of algal compounds |
PCT/US2014/025019 WO2014151116A1 (en) | 2013-03-15 | 2014-03-12 | Conversion of free fatty acids to ethyl esters |
CN201480024225.9A CN105263896A (en) | 2013-03-15 | 2014-03-12 | Conversion of free fatty acids to ethyl esters |
HK16108661.3A HK1220683A1 (en) | 2013-03-15 | 2016-07-20 | Conversion of free fatty acids to ethyl esters |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361800114P | 2013-03-15 | 2013-03-15 | |
US201361800029P | 2013-03-15 | 2013-03-15 | |
US14/025,740 US20140275613A1 (en) | 2013-03-15 | 2013-09-12 | Conversion of free fatty acids to ethyl esters |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140275613A1 true US20140275613A1 (en) | 2014-09-18 |
Family
ID=51527995
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/025,740 Abandoned US20140275613A1 (en) | 2013-03-15 | 2013-09-12 | Conversion of free fatty acids to ethyl esters |
US14/025,772 Active US9445619B2 (en) | 2013-03-15 | 2013-09-12 | Compositions and methods for utilization of algal compounds |
US14/025,766 Abandoned US20140274922A1 (en) | 2013-03-15 | 2013-09-12 | Algal omega 7 compositions |
US14/025,762 Abandoned US20140275483A1 (en) | 2013-03-15 | 2013-09-12 | Algal oil compositions |
US14/025,756 Abandoned US20140275596A1 (en) | 2013-03-15 | 2013-09-12 | Algal omega 7 and algal omega 3 blend compositions |
US14/218,855 Abandoned US20140273113A1 (en) | 2013-03-15 | 2014-03-18 | Chlorophyll deficient algal cell with improved growth and production |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/025,772 Active US9445619B2 (en) | 2013-03-15 | 2013-09-12 | Compositions and methods for utilization of algal compounds |
US14/025,766 Abandoned US20140274922A1 (en) | 2013-03-15 | 2013-09-12 | Algal omega 7 compositions |
US14/025,762 Abandoned US20140275483A1 (en) | 2013-03-15 | 2013-09-12 | Algal oil compositions |
US14/025,756 Abandoned US20140275596A1 (en) | 2013-03-15 | 2013-09-12 | Algal omega 7 and algal omega 3 blend compositions |
US14/218,855 Abandoned US20140273113A1 (en) | 2013-03-15 | 2014-03-18 | Chlorophyll deficient algal cell with improved growth and production |
Country Status (9)
Country | Link |
---|---|
US (6) | US20140275613A1 (en) |
EP (2) | EP2970817A1 (en) |
CN (4) | CN105263896A (en) |
AU (1) | AU2014232150A1 (en) |
CA (2) | CA2906532A1 (en) |
HK (1) | HK1220683A1 (en) |
IL (1) | IL240339A0 (en) |
MX (1) | MX2015012321A (en) |
WO (4) | WO2014151116A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9101942B2 (en) | 2009-06-16 | 2015-08-11 | Aurora Algae, Inc. | Clarification of suspensions |
US9266973B2 (en) | 2013-03-15 | 2016-02-23 | Aurora Algae, Inc. | Systems and methods for utilizing and recovering chitosan to process biological material |
US9445619B2 (en) | 2013-03-15 | 2016-09-20 | Aurora Algae, Inc. | Compositions and methods for utilization of algal compounds |
US9629820B2 (en) | 2012-12-24 | 2017-04-25 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
US10123986B2 (en) | 2012-12-24 | 2018-11-13 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
WO2021077027A1 (en) * | 2019-10-17 | 2021-04-22 | The Regents Of The University Of California | Biologically-derived fatty acids and polymers |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2892821C (en) | 2012-12-06 | 2022-04-26 | Synthetic Genomics, Inc. | Algal mutants having a locked-in high light acclimated phenotype |
US9919016B2 (en) * | 2015-02-10 | 2018-03-20 | Bilal Qizilbash | Product and method of deploying kale derivatives for anti-cancer effects |
CN107287252B (en) | 2016-04-01 | 2020-07-10 | 中国科学院青岛生物能源与过程研究所 | Omega-7 fatty acid composition, method for culturing chrysophyceae to produce composition and application |
US11446348B2 (en) | 2017-12-30 | 2022-09-20 | Bilal Qizilbash | Vegetable powders, methods for manufacturing vegetable powders, and kits thereof |
EP3890761A4 (en) * | 2018-12-06 | 2022-11-30 | James Cook University | Novel composition |
US20230014004A1 (en) * | 2019-12-05 | 2023-01-19 | Vaxa Technologies Ltd | Nutritional supplement for animal and aquacutlure diet and method of making same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3642844A (en) * | 1968-08-30 | 1972-02-15 | British Petroleum Co | Method of preparing carboxylic acids and their esters from lipid extracts |
US20110072713A1 (en) * | 2009-09-30 | 2011-03-31 | Daniel Fleischer | Processing Lipids |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8819110D0 (en) | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
AU6821294A (en) * | 1993-04-30 | 1994-11-21 | Rodner R. Winget | Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto |
AU5137901A (en) * | 2000-04-06 | 2001-10-23 | Coastside Res | Method to inhibit lipoxygenase and cancer cell proliferation |
JPWO2002077105A1 (en) | 2001-03-22 | 2004-07-15 | 富士化学工業株式会社 | Stable astaxanthin-containing powder composition and method for producing the same |
US7119117B2 (en) * | 2001-08-21 | 2006-10-10 | Galileo Pharmaceuticals, Inc. | Tocopherol enriched compositions and amelioration of inflammatory symptoms |
CA2656311C (en) * | 2006-07-05 | 2016-06-21 | Photonz Corporation Limited | Ultra pure epa and polar lipids produced in largely heterotrophic culture |
CN101932714A (en) | 2007-12-04 | 2010-12-29 | 俄亥俄州立大学研究基金会 | Optimization of biofuel production |
US20090311367A1 (en) | 2008-06-17 | 2009-12-17 | Perry Stephen C | Dietary Supplement |
WO2010027505A2 (en) * | 2008-09-05 | 2010-03-11 | Doron Eisenstadt | Decreasing rubisco content of algae and cyanobacteria cultivated in high carbon dioxide |
US8367392B2 (en) * | 2008-09-05 | 2013-02-05 | Transalgae Ltd. | Genetic transformation of algal and cyanobacteria cells by microporation |
US20100130608A1 (en) * | 2008-10-01 | 2010-05-27 | Martek Biosciences Corporation | Compositions and methods for reducing triglyceride levels |
US9187778B2 (en) * | 2009-05-04 | 2015-11-17 | Aurora Algae, Inc. | Efficient light harvesting |
WO2011097276A1 (en) * | 2010-02-02 | 2011-08-11 | Martek Biosciences Corporation | Methods and compositions for treating arthritis with docosahexaenoic acid |
CA2794854A1 (en) * | 2010-04-06 | 2011-10-13 | Heliae Development, Llc | Methods of and systems for producing biofuels |
US8603094B2 (en) * | 2010-07-26 | 2013-12-10 | Spinal Usa, Inc. | Minimally invasive surgical tower access devices and related methods |
WO2012052468A2 (en) * | 2010-10-21 | 2012-04-26 | Basf Plant Science Company Gmbh | Novel fatty acid desaturases, elongases, elongation components and uses therof |
WO2012109539A1 (en) | 2011-02-11 | 2012-08-16 | E. I. Du Pont De Nemours And Company | An eicosapentaenoic acid concentrate |
US20120213713A1 (en) * | 2011-02-18 | 2012-08-23 | Chifu Huang | Compositions of omega fatty acids for the prevention and treatment of dental caries resulting from oral infections |
KR20140010126A (en) | 2011-03-03 | 2014-01-23 | 터서스 파마수티칼 엘엘씨 | Compositions and methods comprising c16:1n7-palmitoleate |
US8569530B2 (en) * | 2011-04-01 | 2013-10-29 | Aurora Algae, Inc. | Conversion of saponifiable lipids into fatty esters |
ES2857173T3 (en) * | 2011-07-21 | 2021-09-28 | Dsm Ip Assets Bv | Microbial oils enriched in polyunsaturated fatty acids |
WO2013075116A2 (en) | 2011-11-17 | 2013-05-23 | Heliae Development, Llc | Omega 7 rich compositions and methods of isolating omega 7 fatty acids |
US20140275613A1 (en) | 2013-03-15 | 2014-09-18 | Aurora Algae, Inc. | Conversion of free fatty acids to ethyl esters |
-
2013
- 2013-09-12 US US14/025,740 patent/US20140275613A1/en not_active Abandoned
- 2013-09-12 US US14/025,772 patent/US9445619B2/en active Active
- 2013-09-12 US US14/025,766 patent/US20140274922A1/en not_active Abandoned
- 2013-09-12 US US14/025,762 patent/US20140275483A1/en not_active Abandoned
- 2013-09-12 US US14/025,756 patent/US20140275596A1/en not_active Abandoned
-
2014
- 2014-03-12 CA CA2906532A patent/CA2906532A1/en not_active Abandoned
- 2014-03-12 CN CN201480024225.9A patent/CN105263896A/en active Pending
- 2014-03-12 WO PCT/US2014/025019 patent/WO2014151116A1/en active Application Filing
- 2014-03-12 CN CN201480015962.2A patent/CN105102598A/en active Pending
- 2014-03-12 WO PCT/US2014/025012 patent/WO2014151113A1/en active Application Filing
- 2014-03-12 EP EP14769076.2A patent/EP2970817A1/en not_active Withdrawn
- 2014-03-12 CA CA2905846A patent/CA2905846A1/en not_active Abandoned
- 2014-03-12 WO PCT/US2014/025007 patent/WO2014151110A1/en active Application Filing
- 2014-03-12 CN CN201480022992.6A patent/CN105209034A/en active Pending
- 2014-03-12 EP EP14767703.3A patent/EP2968244A4/en not_active Withdrawn
- 2014-03-18 US US14/218,855 patent/US20140273113A1/en not_active Abandoned
- 2014-03-18 MX MX2015012321A patent/MX2015012321A/en unknown
- 2014-03-18 CN CN201480013299.2A patent/CN105121623A/en active Pending
- 2014-03-18 AU AU2014232150A patent/AU2014232150A1/en not_active Abandoned
- 2014-03-18 WO PCT/US2014/031127 patent/WO2014146133A2/en active Application Filing
-
2015
- 2015-08-04 IL IL240339A patent/IL240339A0/en unknown
-
2016
- 2016-07-20 HK HK16108661.3A patent/HK1220683A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3642844A (en) * | 1968-08-30 | 1972-02-15 | British Petroleum Co | Method of preparing carboxylic acids and their esters from lipid extracts |
US20110072713A1 (en) * | 2009-09-30 | 2011-03-31 | Daniel Fleischer | Processing Lipids |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9101942B2 (en) | 2009-06-16 | 2015-08-11 | Aurora Algae, Inc. | Clarification of suspensions |
US9629820B2 (en) | 2012-12-24 | 2017-04-25 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
US10039734B2 (en) | 2012-12-24 | 2018-08-07 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
US10123986B2 (en) | 2012-12-24 | 2018-11-13 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
US9266973B2 (en) | 2013-03-15 | 2016-02-23 | Aurora Algae, Inc. | Systems and methods for utilizing and recovering chitosan to process biological material |
US9445619B2 (en) | 2013-03-15 | 2016-09-20 | Aurora Algae, Inc. | Compositions and methods for utilization of algal compounds |
WO2021077027A1 (en) * | 2019-10-17 | 2021-04-22 | The Regents Of The University Of California | Biologically-derived fatty acids and polymers |
Also Published As
Publication number | Publication date |
---|---|
CN105121623A (en) | 2015-12-02 |
CN105263896A (en) | 2016-01-20 |
US20140271706A1 (en) | 2014-09-18 |
EP2968244A1 (en) | 2016-01-20 |
WO2014151113A1 (en) | 2014-09-25 |
CN105209034A (en) | 2015-12-30 |
IL240339A0 (en) | 2015-09-24 |
US20140273113A1 (en) | 2014-09-18 |
US20140275483A1 (en) | 2014-09-18 |
EP2970817A1 (en) | 2016-01-20 |
US20140274922A1 (en) | 2014-09-18 |
WO2014146133A3 (en) | 2014-11-06 |
WO2014151110A1 (en) | 2014-09-25 |
WO2014146133A2 (en) | 2014-09-18 |
US9445619B2 (en) | 2016-09-20 |
MX2015012321A (en) | 2015-12-16 |
US20140275596A1 (en) | 2014-09-18 |
WO2014151116A1 (en) | 2014-09-25 |
CN105102598A (en) | 2015-11-25 |
EP2968244A4 (en) | 2016-10-26 |
HK1220683A1 (en) | 2017-05-12 |
AU2014232150A1 (en) | 2015-08-20 |
CA2906532A1 (en) | 2014-09-25 |
CA2905846A1 (en) | 2014-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20140275613A1 (en) | Conversion of free fatty acids to ethyl esters | |
Akoh | Food lipids: chemistry, nutrition, and biotechnology | |
Wei et al. | Human milk fat substitutes: Past achievements and current trends | |
O’Keefe | Nomenclature and classification of lipids | |
Sahin et al. | Lipase-catalyzed acidolysis of tripalmitin with hazelnut oil fatty acids and stearic acid to produce human milk fat substitutes | |
US8569530B2 (en) | Conversion of saponifiable lipids into fatty esters | |
US20130274490A1 (en) | Extraction of Lipids From Algae | |
Wang et al. | Establishment of an evaluation model for human milk fat substitutes | |
Turan et al. | Production of human milk fat analogue containing docosahexaenoic and arachidonic acids | |
EP2585570B1 (en) | Process for separating polyunsaturated fatty acids from long chain unsaturated or less saturated fatty acids | |
He et al. | Production of new human milk fat substitutes by enzymatic acidolysis of microalgae oils from Nannochloropsis oculata and Isochrysis galbana | |
Teichert et al. | Stearidonic acid soybean oil enriched with palmitic acid at the sn-2 position by enzymatic interesterification for use as human milk fat analogues | |
WO2004052115A1 (en) | Glyceride compositions and methods of making and using same | |
Ang et al. | Preparation and functionality of lipase-catalysed structured phospholipid–A review | |
Zhang et al. | Concentration of omega-3 polyunsaturated fatty acids from oil of Schizochytrium limacinum by molecular distillation: optimization of technological conditions | |
Zou et al. | Lipozyme RM IM-catalyzed acidolysis of Cinnamomum camphora seed oil with oleic acid to produce human milk fat substitutes enriched in medium-chain fatty acids | |
Teichert et al. | Modifications of stearidonic acid soybean oil by enzymatic acidolysis for the production of human milk fat analogues | |
Yüksel et al. | Enzymatic production of human milk fat analogues containing stearidonic acid and optimization of reactions by response surface methodology | |
Zhang et al. | Two-stage enzymatic preparation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) enriched fish oil triacylglycerols | |
Ratledge | Microbial production of polyunsaturated fatty acids as nutraceuticals | |
Xue et al. | Development prospect and preparation technology of edible oil from microalgae | |
Wang et al. | An efficient synthesis of lysophosphatidylcholine enriched with n-3 polyunsaturated fatty acids by immobilized MAS1 lipase | |
Wang et al. | Effect of solvent on acyl migration of 2-monoacylglycerols in enzymatic ethanolysis | |
Robert et al. | Rapeseed lecithin increases lymphatic lipid output and α-linolenic acid bioavailability in rats | |
CN106893747B (en) | Preparation method of PLA1 type n-3 polyunsaturated fatty acid phospholipid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AURORA ALGAE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HIPPLER, JEFFREY GERARD;KAPICAK, LOUIS ANTHONY;POTTER, KRISTEN;SIGNING DATES FROM 20130911 TO 20130912;REEL/FRAME:032032/0549 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |